synairgen.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Breakthrough Science for Severe Viral Lung Infections - |
| Description | Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 193.39.252.126 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
synairgen.com Valuation
|
US$5,341,675
Last updated: 2023-05-10 17:22:09
synairgen.com has Semrush global rank of 1,981,458. synairgen.com has an estimated worth of US$ 5,341,675, based on its estimated Ads revenue. synairgen.com receives approximately 616,348 unique visitors each day. Its web server is located in -, with IP address 193.39.252.126. According to SiteAdvisor, synairgen.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,341,675 |
| Daily Ads Revenue | US$4,931 |
| Monthly Ads Revenue | US$147,924 |
| Yearly Ads Revenue | US$1,775,080 |
| Daily Unique Visitors | 41,090 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| synairgen.com. | A | 3599 | IP: 193.39.252.126 |
| synairgen.com. | NS | 3600 | NS Record: ns19.domaincontrol.com. |
| synairgen.com. | NS | 3600 | NS Record: ns20.domaincontrol.com. |
| synairgen.com. | MX | 3600 | MX Record: 10 cluster8.eu.messagelabs.com. |
| synairgen.com. | MX | 3600 | MX Record: 20 cluster8a.eu.messagelabs.com. |
| synairgen.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.messagelabs.com include:spf.protection.outlook.com ip4:82.118.99.88 ip4:81.3.106.76 ip4:152.78.6.45 ip4:152.78.7.234 -all |
| synairgen.com. | TXT | 3600 | TXT Record: MS=ms48648822 |
HtmlToTextCheckTime:2023-05-10 17:22:09
| Home About + Our Story Meet the Team FAQs Our Science + Inhaled IFN-β Clinical Trials Publications Investors + Share Price Information Reports & Presentations Investor News Shareholder Information AIM Rule 26 Corporate Governance Investor Calendar News + Press Releases Resources Factsheets TR-1/Options Press Releases Careers Contact Home About Our Science Investors News Careers Contact Back Our Story Meet the Team FAQs Back Inhaled IFN-β Clinical Trials Publications Back Share Price Information Reports & Presentations Investor News Shareholder Information AIM Rule 26 Corporate Governance Investor Calendar Back Press Releases Resources Factsheets TR-1/Options Press Releases Breakthrough Science for Severe Viral Lung Infections We are a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta (IFN-β) for the treatment of severe viral lung infections as potentially the first host-directed, broad-spectrum antiviral treatment |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Length: 148
Content-Type: text/html; charset=UTF-8
Location: http://www.synairgen.com/
Server: Microsoft-IIS/10.0
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Content-Security-Policy: default-src https: 'unsafe-inline' synairgen.web01.hosting.bdci.co.uk; connect-src wss: https: synairgen.web01.hosting.bdci.co.uk; style-src https: 'self' 'unsafe-inline' cdn.jsdelivr.net; script-src https: 'self' 'unsafe-inline' 'unsafe-eval' cdn.jsdelivr.net maps.googleapis.com www.googletagmanager.com www.google-analytics.com; img-src https: data: 'self';
Permissions-Policy: accelerometer=('none'); camera=('none'); geolocation=('none'); gyroscope=('none'); magnetometer=('none'); microphone=('none'); payment=('none'); usb=('none')
Date: Wed, 03 Nov 2021 03:53:41 GMT
Set-Cookie: SERVERID=WEB-DB-02; path=/
Cache-control: private
HTTP/1.1 301 Moved Permanently
Content-Length: 149
Content-Type: text/html; charset=UTF-8
Location: https://www.synairgen.com/
Server: Microsoft-IIS/10.0
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Content-Security-Policy: default-src https: 'unsafe-inline' synairgen.web01.hosting.bdci.co.uk; connect-src wss: https: synairgen.web01.hosting.bdci.co.uk; style-src https: 'self' 'unsafe-inline' cdn.jsdelivr.net; script-src https: 'self' 'unsafe-inline' 'unsafe-eval' cdn.jsdelivr.net maps.googleapis.com www.googletagmanager.com www.google-analytics.com; img-src https: data: 'self';
Permissions-Policy: accelerometer=('none'); camera=('none'); geolocation=('none'); gyroscope=('none'); magnetometer=('none'); microphone=('none'); payment=('none'); usb=('none')
Date: Wed, 03 Nov 2021 03:53:41 GMT
Set-Cookie: SERVERID=WEB-DB-02; path=/
Cache-control: private
HTTP/2 200
cache-control: private
content-length: 18405
content-type: text/html; charset=utf-8
request-context: appId=cid-v1:0ef9a294-222d-462d-bcca-c324c0df8670
access-control-expose-headers: Request-Context
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
x-xss-protection: 1; mode=block
referrer-policy: no-referrer-when-downgrade
content-security-policy: default-src https: 'unsafe-inline' synairgen.web01.hosting.bdci.co.uk; connect-src wss: https: synairgen.web01.hosting.bdci.co.uk; style-src https: 'self' 'unsafe-inline' cdn.jsdelivr.net; script-src https: 'self' 'unsafe-inline' 'unsafe-eval' cdn.jsdelivr.net maps.googleapis.com www.googletagmanager.com www.google-analytics.com; img-src https: data: 'self';
permissions-policy: accelerometer=('none'); camera=('none'); geolocation=('none'); gyroscope=('none'); magnetometer=('none'); microphone=('none'); payment=('none'); usb=('none')
date: Wed, 03 Nov 2021 03:53:41 GMT
|
synairgen.com Whois Information
Domain Name: SYNAIRGEN.COM Registry Domain ID: 95944948_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-01T11:03:45Z Creation Date: 2003-03-19T15:01:13Z Registry Expiry Date: 2022-03-19T14:01:13Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS19.DOMAINCONTROL.COM Name Server: NS20.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-29T09:01:09Z <<< |